← Open Payments lookup

ANNALEE ALDAPE: Open Payments

NPI 1730945478 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,323 in 154 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,018 · 2025 $3,323

Food & beverage: $3,323
CompanyPaymentsAmount
ABBVIE INC.44$715
Ipsen Biopharmaceuticals, Inc14$438
Madrigal Pharmaceuticals12$426
Janssen Biotech, Inc.10$375
Phathom Pharmaceuticals, Inc.14$273
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$206
Gilead Sciences, Inc.11$184
Takeda Pharmaceuticals U.S.A., Inc.10$183
Lilly USA, LLC10$161
GENZYME CORPORATION5$145

Products named: REZDIFFRA, TREMFYA, IQIRVO, VOQUEZNA, LINZESS, XIFAXAN, RINVOQ, DUPIXENT.

Industry payments across TX — which companies pay providers there.